Corcept Therapeutics | CORT - Pre Utilidad Fiscal





Pre Utilidad Fiscal Cambio Fecha
Acadia Pharmaceuticals USD 3.98M 22.34M 2026-03
Alaunos Therapeutics USD -7.84M 633K 2023-12
ANI Pharmaceuticals USD 31.48M 18.04M 2025-12
Ardelyx USD -37.6M 37.2M 2026-03
Aurora Cannabis CAD 11.41M 12.99M 2026-03
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Canopy Growth CAD -157.96M 95.71M 2026-03
Corcept Therapeutics USD -44.72M 54.62M 2026-03
Eli Lilly USD 8.27B 1.03B 2025-12
J&J USD 8.66B 839M 2026-06
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Lexicon Pharmaceuticals USD -12.77M 16.02M 2025-09
Merck USD 3.42B 3.32B 2025-12
Nektar Therapeutics USD -34.7M 2.35M 2025-12
Novartis USD 4.27B 430M 2026-06
Novartis USD 3.84B 1.33B 2026-03
Omeros USD -65.12M 21.27M 2024-06
Pacira USD 571K 8.95M 2025-12
Pfizer USD 5.18B 6.82B 2026-03
Supernus Pharmaceuticals USD -5.95M 4.04M 2026-03
TG Therapeutics USD 20.36M 24.73M 2026-03